法国南部抗中性粒细胞胞质抗体相关性血管炎的患病率:采用捕获-再捕获方法
这项基于人群的横断面研究利用四类来源在法国南部2018年识别202例成人AAV患者,标准化患病率为每百万居民103例(95%CI 84-125),捕获-再捕获分析估计完整性为80.5%,非欧洲居民AAV病例数更高(P=0.001),尤其是MPA(P<0.0001)。
要点
- 2018年法国南部AAV标准化患病率为每百万居民103例(95%CI 84-125)。
- GPA、MPA、EGPA标准化患病率分别为每百万48、39、16例。
- 非欧洲居民AAV病例数更高(P=0.001),MPA尤为明显(P<0.0001)。
核心结论
- 研究提供了法国AAV患病率的新估计,并显示非欧洲患者中MPA患病率更高。
研究设计与样本
- 基于人群的横断面研究,使用医院、社区医生、实验室、国家健康保险四类来源识别2018年居住在埃罗省和加尔省的≥15岁GPA、MPA或EGPA患者。
- 病例定义采用ACR/EULAR分类标准,必要时采用欧洲药品管理局算法。
- 患病率估计标准化至世界人口,并采用捕获-再捕获分析评估估计完整性。
主要发现
- 共纳入202例患者,其中GPA 86例(42.6%)、MPA 85例(42.1%)、EGPA 31例(15.3%)。
- 2018年每百万居民标准化患病率:AAV 103(95%CI 84-125),GPA 48(95%CI 35-64),MPA 39(95%CI 28-53),EGPA 16(95%CI 9-26)。
- 抗PR3阳性AAV标准化患病率为每百万36例(95%CI 25-50),抗MPO阳性AAV为46例(95%CI 34-61),ANCA阴性AAV为16例(95%CI 9-26)。
- 捕获-再捕获分析估计总体完整性为80.5%。
- 非欧洲居民AAV病例数更高(P=0.001),尤其是MPA(P<0.0001)。
关键数值与推荐
- 病例定义采用ACR/EULAR分类标准,必要时采用欧洲药品管理局算法。
- 患病率估计标准化至世界人口。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to estimate the prevalence of ANCA-associated vasculitis (AAV). That is, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), in Southern France in 2018, and evaluate differences among Europeans and non-Europeans. METHODS: This population-based, cross-sectional study used four sources (hospitals, community-based physicians, laboratories, National Health Insurance) to identify adults ≥15 years diagnosed with GPA, MPA or EGPA, living in Hérault and Gard in 2018. Cases were defined using the ACR/EULAR classification criteria, and if necessary, the European Medicines Agency algorithm. Prevalence estimates were standardised to the world population and capture-recapture analysis was used to assess the comprehensiveness of the estimation. The influence of geographical origin was evaluated. RESULTS: A total of 202 patients were selected, with 86 cases of GPA (42.6%), 85 cases of MPA (42.1%) and 31 cases of EGPA (15.3%). The standardised prevalence estimates per million inhabitants for 2018 were: 103 (95%CI 84-125) for AAV, 48 (95%CI 35-64) for GPA, 39 (95%CI 28-53) for MPA and 16 (95%CI 9-26) for EGPA, 36 (95%CI 25-50) for anti-PR3 positive AAV, 46 (95%CI 34-61) for anti-MPO positive AAV, and 16 (95%CI 9-26) for ANCA-negative AAV. The global estimation of comprehensiveness by capture-recapture analysis was 80.5%. The number of AAV cases was higher for non-European residents (P = 0.001), particularly for MPA (P < 0.0001). CONCLUSION: We provide a new estimate of AAV prevalence in France and show a higher prevalence of MPA in non-European patients.
引用
- Rubenstein E, Henneton P, Rivière S, et al. Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method. Rheumatology (Oxford). 2024. PMID: 37819770. doi:10.1093/rheumatology/kead557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。